Enolamides, pharmaceutical compositions and methods for treating
申请人:Warner-Lambert Company
公开号:US04761424A1
公开(公告)日:1988-08-02
The present invention relates to novel enolamide type compounds, pharmaceutical compositions, and methods of use thereof, useful in the treatment of diseases in which products of lipoxygenase enzyme activity or the action of leukotrienes contribute to the pathological condition.
A fast and highly enantioselectivefluorination of [small beta]-keto esters catalyzed by diphenylamine linked bis(oxazoline)-Cu(OTf)2 complexes under solvent-free conditions has been developed using a planetary ball mill.
A highly enantioselectiveconjugateaddition of 2-substituted benzofuran-3(2H)-ones to α,β-unsaturated ketones promoted by chiral copper complexes has been developed, affording the Michaeladdition products with quaternary stereocenters in good to high yields (up to 95% yield) with excellent enantioselectivities (up to 99% ee). The chiralMichael adducts could be readily converted to the polycyclic
Novel enolamides, process for their manufacture and pharmaceutical compositions thereof with an activity as modulators of the arachidonic acid cascade
申请人:WARNER-LAMBERT COMPANY
公开号:EP0221345A1
公开(公告)日:1987-05-13
The present invention relates to novel enolamide type compounds, pharmaceutical compositions, and methods of use thereof, useful in the treatment of diseases in which products of lipoxygenase enzyme activity or the action of leukotrienes contribute to the pathological condition.